NDC 51991-331

Nevirapine

Nevirapine

Nevirapine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Nevirapine.

Product ID51991-331_5c7e2529-a647-4ce1-a793-b003df0841a9
NDC51991-331
Product TypeHuman Prescription Drug
Proprietary NameNevirapine
Generic NameNevirapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-04-11
Marketing End Date2021-05-31
Marketing CategoryANDA / ANDA
Application NumberANDA078644
Labeler NameBreckenridge Pharmaceutical, Inc.
Substance NameNEVIRAPINE
Active Ingredient Strength200 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC Exclude FlagN

Packaging

NDC 51991-331-06

60 TABLET in 1 BOTTLE (51991-331-06)
Marketing Start Date2011-04-11
Marketing End Date2021-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51991-331-06 [51991033106]

Nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA078644
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-04-11
Marketing End Date2021-05-31

Drug Details

Active Ingredients

IngredientStrength
NEVIRAPINE200 mg/1

OpenFDA Data

SPL SET ID:b3e740ad-46d9-48f5-85ab-7c319919ceb1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199422
  • UPC Code
  • 0351991331063
  • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]

    Medicade Reported Pricing

    51991033106 NEVIRAPINE 200 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Nevirapine" or generic name "Nevirapine"

    NDCBrand NameGeneric Name
    0378-4050Nevirapinenevirapine
    0378-4890Nevirapinenevirapine
    0378-6950Nevirapinenevirapine
    0781-5893NevirapineNevirapine
    31722-505NevirapineNevirapine
    33342-004NevirapineNevirapine
    33342-238NEVIRAPINENEVIRAPINE
    42571-131NEVIRAPINENEVIRAPINE
    51991-331NevirapineNEVIRAPINE
    53104-0166nevirapinenevirapine
    53808-0680Nevirapinenevirapine
    53808-1069nevirapinenevirapine
    61442-470NevirapineNevirapine
    64380-709NevirapineNevirapine
    65162-209NevirapineNevirapine
    69097-403NEVIRAPINENEVIRAPINE
    69097-233nevirapinenevirapine
    65862-057NevirapineNevirapine
    65862-027NevirapineNevirapine
    65862-932NEVIRAPINENEVIRAPINE
    65862-933NEVIRAPINENEVIRAPINE
    47781-317Nevirapine Extended Releasenevirapine
    0597-0046Viramunenevirapine
    0597-0047Viramunenevirapine
    0597-0123Viramunenevirapine
    53808-0808Viramunenevirapine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.